• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对全球收集的富含产超广谱β-内酰胺酶生物体的肠杆菌科细菌进行头孢吡肟最低抑菌浓度和纸片扩散试验抑菌圈直径关系的重新评估。

Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.

作者信息

Pottumarthy Sudha, Deshpande Lalitagauri M, Sader Helio S, Jones Ronald N

机构信息

JMI Laboratories, North Liberty, IA 52317, USA.

出版信息

Diagn Microbiol Infect Dis. 2005 Jun;52(2):95-9. doi: 10.1016/j.diagmicrobio.2004.12.004.

DOI:10.1016/j.diagmicrobio.2004.12.004
PMID:15964496
Abstract

To reassess the validity of existing susceptibility breakpoint criteria and to propose alternative breakpoint criteria for disk diffusion testing at lower susceptible MIC breakpoints, we analyzed a contemporary global collection of Enterobacteriaceae isolates (350) strains enriched for extended-spectrum beta-lactamase (ESBL) producers (68 strains, 19.4%). The majority of the isolates (88.3% of the entire collection and 83.8% of the ESBL subset) were from bloodstream infections. Cefepime minimal inhibitory concentrations (MICs) were determined by broth microdilution methods and compared with the results obtained from disk diffusion testing for the entire collection of Enterobacteriaceae and for the ESBL subset alone. The regression coefficient was excellent for both scattergrams (r = 0.92-0.94). The intermethod categorical agreement remained excellent for the current breakpoints (susceptible at < or = 8 microg/mL or > or = 18 mm and resistant at > or = 32 microg/mL or < or = 14 mm) published by the National Committee for Clinical Laboratory Standards at 94.0%. The 2 alternative interpretive criteria considered at lower MIC breakpoints (i.e., susceptible as < or = 4 microg/mL and > or = 21 mm and susceptible as < or = 2 microg/mL and > or = 24 mm) did not compromise the intermethod test categorical accuracy, which remained excellent at 96.9% and 94.0%, respectively. Adopting the existing breakpoint criteria that remain accurate for ESBL-producing strains or any one of the above two alternative sets of breakpoint criteria analyzed would be acceptable, with excellent intermethod concordance between the MIC and disk diffusion results.

摘要

为重新评估现有药敏折点标准的有效性,并针对较低敏感 MIC 折点的纸片扩散法检测提出替代折点标准,我们分析了一组当代全球收集的肠杆菌科分离株(350 株),其中富含超广谱β-内酰胺酶(ESBL)产生菌(68 株,占 19.4%)。大多数分离株(占整个收集菌株的 88.3%以及 ESBL 亚组的 83.8%)来自血流感染。通过肉汤微量稀释法测定头孢吡肟的最低抑菌浓度(MIC),并将其与整个肠杆菌科收集菌株以及单独的 ESBL 亚组的纸片扩散法检测结果进行比较。两个散点图的回归系数都非常好(r = 0.92 - 0.94)。对于美国国家临床实验室标准委员会公布的当前折点(≤8 μg/mL 或≥18 mm 为敏感,≥32 μg/mL 或≤14 mm 为耐药),方法间分类一致性仍非常好,为 94.0%。在较低 MIC 折点考虑的两个替代解释标准(即≤4 μg/mL 且≥21 mm 为敏感,≤2 μg/mL 且≥24 mm 为敏感)并未损害方法间检测分类准确性,分别仍保持在 96.9%和 94.0%的高水平。采用对产 ESBL 菌株仍然准确的现有折点标准或上述分析的两组替代折点标准中的任何一组都是可以接受的,MIC 和纸片扩散法结果之间的方法间一致性非常好。

相似文献

1
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.对全球收集的富含产超广谱β-内酰胺酶生物体的肠杆菌科细菌进行头孢吡肟最低抑菌浓度和纸片扩散试验抑菌圈直径关系的重新评估。
Diagn Microbiol Infect Dis. 2005 Jun;52(2):95-9. doi: 10.1016/j.diagmicrobio.2004.12.004.
2
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.对9种β-内酰胺类药物的肠杆菌科细菌最低抑菌浓度/纸片扩散法抑菌圈直径回归散点图的重新评估:对产超广谱β-内酰胺酶菌株的断点调整
Diagn Microbiol Infect Dis. 2005 Jul;52(3):235-46. doi: 10.1016/j.diagmicrobio.2005.02.006.
3
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.产CTX-M型超广谱β-内酰胺酶的肠杆菌科细菌群体的药敏试验准确性:9种β-内酰胺类药物的方法间分析
Diagn Microbiol Infect Dis. 2005 Oct;53(2):131-41. doi: 10.1016/j.diagmicrobio.2005.02.012. Epub 2005 Jun 4.
4
Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.2007 年台湾地区多重抗药性监测计划(SMART):从加护病房临床重要肠杆菌科分离菌检测超广谱β内醯胺酶产生与头孢吡肟最低抑菌浓度分布之关系。
J Microbiol Immunol Infect. 2015 Feb;48(1):85-91. doi: 10.1016/j.jmii.2013.07.002. Epub 2013 Aug 22.
5
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.比较欧洲抗菌药物敏感性试验委员会(EUCAST)和 CLSI 筛选参数在检测临床肠杆菌科分离株产超广谱β-内酰胺酶中的应用。
J Antimicrob Chemother. 2012 Jan;67(1):159-66. doi: 10.1093/jac/dkr400. Epub 2011 Oct 3.
6
Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.肠杆菌属在台湾的广泛β-内酰胺酶的流行情况和 3 种表型确证方法检测广泛β-内酰胺酶产生的比较。
J Microbiol Immunol Infect. 2009 Aug;42(4):310-6.
7
Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.评估一种新型头孢吡肟-克拉维酸Etest用于检测肠杆菌科菌株中广谱β-内酰胺酶的性能。
J Antimicrob Chemother. 2004 Jul;54(1):134-8. doi: 10.1093/jac/dkh274. Epub 2004 May 18.
8
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.多利培南对全球收集的肠杆菌科细菌的活性进行了测试,包括对其他广谱抗菌药物耐药的分离株。
Diagn Microbiol Infect Dis. 2009 Apr;63(4):415-25. doi: 10.1016/j.diagmicrobio.2009.02.002. Epub 2009 Feb 26.
9
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.台湾地区针对替加环素对产超广谱β-内酰胺酶肠杆菌科临床分离株的体外活性开展的全国性监测。
Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S179-83. doi: 10.1016/S0924-8579(08)70024-4.
10
Extended spectrum beta lactamase--mediated resistance among isolates of family Enterobacteriaceae.肠杆菌科细菌分离株中由超广谱β-内酰胺酶介导的耐药性
Indian J Pathol Microbiol. 2007 Apr;50(2):458-61.

引用本文的文献

1
Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-β-lactamase-producing Escherichia coli.在对产超广谱β-内酰胺酶的大肠埃希菌进行头孢吡肟敏感性的Vitek 2检测中,错误率高得令人无法接受。
Antimicrob Agents Chemother. 2014 Jul;58(7):3757-61. doi: 10.1128/AAC.00041-14. Epub 2014 Apr 21.